1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients

BACKGROUND: Cefiderocol (CFDC), a novel siderophore cephalosporin, has demonstrated potent antibacterial activity against a wide range of Gram-negative bacteria including carbapenem-resistant strains. We aimed to evaluate relationships between drug exposure and outcomes in critically ill patients. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Katsube, Takayuki, Kawaguchi, Nao, Matsunaga, Yuko, Ariyasu, Mari, Den Nagata, Tsutae, Portsmouth, Simon, Paterson, David, Satlin, Michael J, Zeitlinger, Markus, Echols, Roger, Wajima, Toshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7777002/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1498
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados